These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 968174)
1. Serum levels of 5-hydroxyindole derivates after administration of L-5-hydroxytryptophan ethyl ester. Korf J; Sebens JB; Venema K; van Praag HM Res Commun Chem Pathol Pharmacol; 1976 Sep; 15(1):171-82. PubMed ID: 968174 [TBL] [Abstract][Full Text] [Related]
2. An unexpected effect of L-5 hydroxytryptophan-ethyl-ester combined with a peripheral decarboxylase inhibitor on human serum prolactin. van Praag HM; Korf J; Lequin RM Psychopharmacol Commun; 1976; 2(5-6):369-78. PubMed ID: 1088302 [TBL] [Abstract][Full Text] [Related]
3. Brain and peripheral metabolism of 5-hydroxytryptophan-14C following peripheral decarboxylase inhibition. Warsh JJ; Stancer HC J Pharmacol Exp Ther; 1976 Jun; 197(3):545-55. PubMed ID: 1084420 [TBL] [Abstract][Full Text] [Related]
4. Measurement of 5-hydroxyindole compounds during L-5-HTP treatment in depressed patients. Takahashi S; Takahashi R; Masumura I; Miike A Folia Psychiatr Neurol Jpn; 1976; 30(4):461-73. PubMed ID: 1087913 [TBL] [Abstract][Full Text] [Related]
5. Serotonergic disturbances in autistic disorder: L-5-hydroxytryptophan administration to autistic youngsters increases the blood concentrations of serotonin in patients but not in controls. Croonenberghs J; Verkerk R; Scharpe S; Deboutte D; Maes M Life Sci; 2005 Mar; 76(19):2171-83. PubMed ID: 15733932 [TBL] [Abstract][Full Text] [Related]
6. Altered dopamine and serotonin metabolism in the dopamine-denervated and serotonin-hyperinnervated neostriatum of adult rat after neonatal 6-hydroxydopamine. Molina-Holgado E; Dewar KM; Descarries L; Reader TA J Pharmacol Exp Ther; 1994 Aug; 270(2):713-21. PubMed ID: 8071864 [TBL] [Abstract][Full Text] [Related]
7. Plasma accumulation of metabolism of orally administered single dose L-5-hydroxytryptophan in man. Magnussen I; Jensen TS; Rand JH; Van Woert MH Acta Pharmacol Toxicol (Copenh); 1981 Sep; 49(3):184-9. PubMed ID: 6175178 [TBL] [Abstract][Full Text] [Related]
8. Effects of serotonin-active drugs on prolactin secretion in male rats. Jagiełło-Wójtowicz E; Załuska W; Szponar J; Surmaczyńska B; Wójcicki M; Kleinrok Z Pol J Pharmacol Pharm; 1988; 40(1):73-80. PubMed ID: 2467272 [TBL] [Abstract][Full Text] [Related]
9. Use of intravenous microdialysis to monitor changes in serotonin release and metabolism induced by cisplatin in cancer patients: comparative effects of granisetron and ondansetron. Castejon AM; Paez X; Hernandez L; Cubeddu LX J Pharmacol Exp Ther; 1999 Dec; 291(3):960-6. PubMed ID: 10565811 [TBL] [Abstract][Full Text] [Related]
10. [Changes of plasma serotonin precursor metabolite concentrations in postmenopausal women with hot flushes]. Chen Y; Lü X; Huang Y; Xin X; Ye X Zhonghua Fu Chan Ke Za Zhi; 2002 Dec; 37(12):726-8. PubMed ID: 12622915 [TBL] [Abstract][Full Text] [Related]
11. Plasma levels of homovanillic acid, 5-hydroxyindoleacetic acid and cortisol, and serotonin turnover in depressed patients. Mitani H; Shirayama Y; Yamada T; Kawahara R Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):531-4. PubMed ID: 16414168 [TBL] [Abstract][Full Text] [Related]
12. L-5-hydroxytryptophan. Correlation between anticonvulsant effect and increases in levels of 5-hydroxyindoles in plasma and brain. Löscher W; Pagliusi SR; Müller F Neuropharmacology; 1984 Sep; 23(9):1041-8. PubMed ID: 6083501 [TBL] [Abstract][Full Text] [Related]
13. On the tryptophan-serotonin metabolism in manic-depressive disorders. Changes in plasma 5-HT and 5-HIAA levels and urinary 5-HIAA excretion following oral loading of L-5HTP in patients with depression. Amamoto T; Sarai K Hiroshima J Med Sci; 1976 Sep; 25(2-3):135-40. PubMed ID: 1088369 [No Abstract] [Full Text] [Related]
14. Localization and quantification of 5-hydroxytryptophan and serotonin in the central nervous systems of Tritonia and Aplysia. Fickbohm DJ; Lynn-Bullock CP; Spitzer N; Caldwell HK; Katz PS J Comp Neurol; 2001 Aug; 437(1):91-105. PubMed ID: 11477599 [TBL] [Abstract][Full Text] [Related]
15. Plasma 5-hydroxytryptamine (5-HT) in migraine during an attack-free period. Nagata E; Shibata M; Hamada J; Shimizu T; Katoh Y; Gotoh K; Suzuki N Headache; 2006 Apr; 46(4):592-6. PubMed ID: 16643553 [TBL] [Abstract][Full Text] [Related]
16. [Determination of plasma serotonins level in patients with pregnancy induced hypertension]. Zhao W; Zhao L; Zhao W Zhonghua Fu Chan Ke Za Zhi; 1999 Jul; 34(7):406-8. PubMed ID: 11360650 [TBL] [Abstract][Full Text] [Related]
17. Blood 5-hydroxytryptamine, 5-hydroxyindoleacetic acid and melatonin levels in patients with either Huntington's disease or chronic brain injury. Christofides J; Bridel M; Egerton M; Mackay GM; Forrest CM; Stoy N; Darlington LG; Stone TW J Neurochem; 2006 May; 97(4):1078-88. PubMed ID: 16573644 [TBL] [Abstract][Full Text] [Related]
18. Changes in serotonin metabolism may elicit obstructive apnoea in the newborn rat. Hilaire G; Morin D; Lajard AM; Monteau R J Physiol; 1993 Jul; 466():367-81. PubMed ID: 7692042 [TBL] [Abstract][Full Text] [Related]
19. The origin of blood 5-hydroxyindoleacetic acid following L-hydrazine-alpha-methyldopa (MK-486). Warsh JJ; Stancer HC Eur J Pharmacol; 1975 May; 32(1):128-32. PubMed ID: 1080116 [TBL] [Abstract][Full Text] [Related]
20. Release and metabolism of 5-hydroxytryptamine in the cat spinal cord examined with microdialysis. Sorkin LS; Hughes MG; Liu D; Willis WD; McAdoo DJ J Pharmacol Exp Ther; 1991 Apr; 257(1):192-9. PubMed ID: 1708424 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]